| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | laminin-5 complex | 1.14e-04 | 4 | 92 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | stereocilium membrane | 2.84e-04 | 6 | 92 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | B-WICH complex | 5.27e-04 | 8 | 92 | 2 | GO:0110016 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ANKRD13A NCOR1 FAT1 PDE9A EIF4A2 TENM1 ADGRV1 DNAJA1 MVP DICER1 HEPH ITPR3 | 7.97e-04 | 934 | 92 | 12 | GO:0048471 |
| GeneOntologyCellularComponent | laminin complex | 8.43e-04 | 10 | 92 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 8.57e-04 | 96 | 92 | 4 | GO:0070603 | |
| Domain | EIF4A1/2 | 2.40e-05 | 2 | 92 | 2 | IPR031258 | |
| Domain | N-CoR_GPS2_interact | 2.40e-05 | 2 | 92 | 2 | IPR031557 | |
| Domain | GPS2_interact | 2.40e-05 | 2 | 92 | 2 | PF15784 | |
| Domain | Laminin_EGF | 2.57e-05 | 35 | 92 | 4 | PF00053 | |
| Domain | EGF_Lam | 2.57e-05 | 35 | 92 | 4 | SM00180 | |
| Domain | Laminin_EGF | 3.58e-05 | 38 | 92 | 4 | IPR002049 | |
| Domain | Peptidase_M14 | 1.91e-04 | 23 | 92 | 3 | PF00246 | |
| Domain | Peptidase_M14 | 1.91e-04 | 23 | 92 | 3 | IPR000834 | |
| Domain | EGF_LAM_2 | 4.26e-04 | 30 | 92 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 4.26e-04 | 30 | 92 | 3 | PS01248 | |
| Domain | TrpB-like_PLP-dep | 4.96e-04 | 7 | 92 | 2 | IPR001926 | |
| Domain | PALP | 4.96e-04 | 7 | 92 | 2 | PF00291 | |
| Domain | BROMODOMAIN_1 | 7.96e-04 | 37 | 92 | 3 | PS00633 | |
| Domain | Bromodomain | 8.61e-04 | 38 | 92 | 3 | PF00439 | |
| Domain | LAM_G_DOMAIN | 8.61e-04 | 38 | 92 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.00e-03 | 40 | 92 | 3 | PF02210 | |
| Domain | BROMODOMAIN_2 | 1.08e-03 | 41 | 92 | 3 | PS50014 | |
| Domain | BROMO | 1.16e-03 | 42 | 92 | 3 | SM00297 | |
| Domain | Bromodomain | 1.16e-03 | 42 | 92 | 3 | IPR001487 | |
| Domain | - | 1.16e-03 | 42 | 92 | 3 | 1.20.920.10 | |
| Domain | - | 1.25e-03 | 95 | 92 | 4 | 2.60.120.200 | |
| Domain | LamG | 1.32e-03 | 44 | 92 | 3 | SM00282 | |
| Domain | EGF_1 | 1.64e-03 | 255 | 92 | 6 | PS00022 | |
| Domain | EGF-like_CS | 1.84e-03 | 261 | 92 | 6 | IPR013032 | |
| Domain | Helicase_C | 1.93e-03 | 107 | 92 | 4 | PF00271 | |
| Domain | HELICc | 1.93e-03 | 107 | 92 | 4 | SM00490 | |
| Domain | EGF_2 | 1.99e-03 | 265 | 92 | 6 | PS01186 | |
| Domain | Helicase_C | 2.00e-03 | 108 | 92 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 2.07e-03 | 109 | 92 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.07e-03 | 109 | 92 | 4 | PS51192 | |
| Domain | DEXDc | 2.07e-03 | 109 | 92 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.14e-03 | 110 | 92 | 4 | IPR014001 | |
| Domain | Laminin_N | 2.75e-03 | 16 | 92 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 2.75e-03 | 16 | 92 | 2 | PS51117 | |
| Domain | Laminin_N | 2.75e-03 | 16 | 92 | 2 | PF00055 | |
| Domain | LamNT | 2.75e-03 | 16 | 92 | 2 | SM00136 | |
| Domain | Laminin_G | 2.93e-03 | 58 | 92 | 3 | IPR001791 | |
| Domain | CarboxyPept-like_regulatory | 3.11e-03 | 17 | 92 | 2 | IPR008969 | |
| Domain | ConA-like_dom | 4.56e-03 | 219 | 92 | 5 | IPR013320 | |
| Domain | DEAD/DEAH_box_helicase_dom | 5.61e-03 | 73 | 92 | 3 | IPR011545 | |
| Domain | DEAD | 5.61e-03 | 73 | 92 | 3 | PF00270 | |
| Pathway | REACTOME_M_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_MATERNALLY_STORED_FACTORS | 1.62e-05 | 33 | 66 | 4 | M48026 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 9.28e-05 | 51 | 66 | 4 | M665 | |
| Pathway | REACTOME_DEADENYLATION_OF_MRNA | 1.85e-04 | 24 | 66 | 3 | MM15090 | |
| Pathway | REACTOME_DEADENYLATION_OF_MRNA | 2.09e-04 | 25 | 66 | 3 | M13492 | |
| Pathway | BIOCARTA_IRES_PATHWAY | 3.20e-04 | 6 | 66 | 2 | MM1550 | |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 3.27e-04 | 128 | 66 | 5 | M48019 | |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 3.64e-04 | 30 | 66 | 3 | MM15173 | |
| Pathway | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | 4.01e-04 | 31 | 66 | 3 | M669 | |
| Pathway | BIOCARTA_IRES_PATHWAY | 4.47e-04 | 7 | 66 | 2 | M22028 | |
| Pathway | REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX | 4.47e-04 | 7 | 66 | 2 | M27899 | |
| Pubmed | TET2 CNTN4 SF3B1 CELSR3 PDE9A EIF4A1 EIF4A2 TRIM8 ZNF202 ZNF439 DNAJA1 MVP CBS EP300 BRWD3 AGTPBP1 MADD ALPL DOP1B BRWD1 | 1.29e-10 | 1285 | 92 | 20 | 35914814 | |
| Pubmed | MicroRNAs are mediators of androgen action in prostate and muscle. | 7.15e-08 | 4 | 92 | 3 | 21048966 | |
| Pubmed | Direct association between the CREB-binding protein (CBP) and nuclear receptor corepressor (N-CoR). | 7.15e-08 | 4 | 92 | 3 | 17073437 | |
| Pubmed | NCOR1 NCOR2 ARID1B ITSN2 TRIM8 OTUD4 CHD2 NEB CSPP1 CNOT1 EP300 ITPR3 | 1.25e-07 | 638 | 92 | 12 | 31182584 | |
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 14985122 | ||
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 26859354 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 4.08e-07 | 351 | 92 | 9 | 38297188 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 6.20e-07 | 184 | 92 | 7 | 32908313 | |
| Pubmed | NCOR1 NCOR2 RBM15 ARID1B SMG7 MYO1C SSH3 OTUD4 DNAJA1 CSPP1 CNOT1 AGTPBP1 MADD ITPR3 | 6.69e-07 | 1049 | 92 | 14 | 27880917 | |
| Pubmed | CNTN4 NCOR2 TSHZ3 FAT1 R3HCC1L MYO1C FARS2 TENM1 LAMB3 CHD2 ZC3H18 EP300 HEPH AGTPBP1 ALPL | 6.82e-07 | 1215 | 92 | 15 | 15146197 | |
| Pubmed | 9.94e-07 | 8 | 92 | 3 | 24768540 | ||
| Pubmed | 9.94e-07 | 8 | 92 | 3 | 20935208 | ||
| Pubmed | TET2 NCOR1 NCOR2 TSHZ3 FAT1 ARID1B SMG7 MYO1C NFRKB OTUD4 ZNF217 ZC3H18 DNAJA1 CNOT1 SOX13 EP300 | 1.00e-06 | 1429 | 92 | 16 | 35140242 | |
| Pubmed | RBM15 SF3B1 MYO1C EIF4A1 CHD2 ZC3H18 DNAJA1 MVP CNOT1 DICER1 ITPR3 | 1.28e-06 | 653 | 92 | 11 | 22586326 | |
| Pubmed | NCOR2 FAT1 ARID1B SMG7 MYO1C NFRKB ZC3H18 DNAJA1 DICER1 EP300 BRWD3 AGTPBP1 ALPL BRWD1 | 1.39e-06 | 1116 | 92 | 14 | 31753913 | |
| Pubmed | 1.39e-06 | 407 | 92 | 9 | 12693553 | ||
| Pubmed | Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone. | 1.49e-06 | 9 | 92 | 3 | 23640055 | |
| Pubmed | 1.49e-06 | 9 | 92 | 3 | 24821727 | ||
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 2.12e-06 | 10 | 92 | 3 | 30595551 | |
| Pubmed | 2.12e-06 | 10 | 92 | 3 | 12738788 | ||
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 2.91e-06 | 11 | 92 | 3 | 15681609 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOR1 NCOR2 RBM15 SF3B1 MYO1C C9orf78 NFRKB OTUD4 ZNF217 ZC3H18 AGTPBP1 | 6.47e-06 | 774 | 92 | 11 | 15302935 |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 30587503 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 29531310 | ||
| Pubmed | CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas. | 6.92e-06 | 2 | 92 | 2 | 27733359 | |
| Pubmed | A cellular response linking eIF4AI activity to eIF4AII transcription. | 6.92e-06 | 2 | 92 | 2 | 22589333 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 32476269 | ||
| Pubmed | Meiotic maturation failure induced by DICER1 deficiency is derived from primary oocyte ooplasm. | 6.92e-06 | 2 | 92 | 2 | 19129368 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 22944139 | ||
| Pubmed | Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence. | 6.92e-06 | 2 | 92 | 2 | 26614665 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 9015395 | ||
| Pubmed | Regulation of eukaryotic initiation factor 4AII by MyoD during murine myogenic cell differentiation. | 6.92e-06 | 2 | 92 | 2 | 24466343 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 21131350 | ||
| Pubmed | Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling. | 6.92e-06 | 2 | 92 | 2 | 26166430 | |
| Pubmed | Structural requirement for cell adhesion to kalinin (laminin-5). | 6.92e-06 | 2 | 92 | 2 | 7775432 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 19299558 | ||
| Pubmed | Unique forms of human and mouse nuclear receptor corepressor SMRT. | 6.92e-06 | 2 | 92 | 2 | 10077563 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 3046931 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 31488558 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 39106294 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 27622333 | ||
| Pubmed | Evolution of NCoR-1 and NCoR-2 corepressor alternative mRNA splicing in placental mammals. | 6.92e-06 | 2 | 92 | 2 | 31208445 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 9205497 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOR2 PHYKPL CACNB3 SMG7 PDE9A TTC21A MAEA ANKRD11 LAMA3 CHD2 ADGRV1 STEAP2 CNOT1 EP300 BRWD3 | 8.17e-06 | 1489 | 92 | 15 | 28611215 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.10e-05 | 398 | 92 | 8 | 35016035 | |
| Pubmed | 1.13e-05 | 52 | 92 | 4 | 16780588 | ||
| Pubmed | 1.16e-05 | 529 | 92 | 9 | 14621295 | ||
| Pubmed | 1.19e-05 | 17 | 92 | 3 | 19183483 | ||
| Pubmed | 1.98e-05 | 20 | 92 | 3 | 11877444 | ||
| Pubmed | Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus. | 2.07e-05 | 3 | 92 | 2 | 16030140 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 8012114 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 31791371 | ||
| Pubmed | Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor. | 2.07e-05 | 3 | 92 | 2 | 19098224 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 16373395 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 31404087 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 9019243 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 22563463 | ||
| Pubmed | Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia. | 2.07e-05 | 3 | 92 | 2 | 17482449 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 22337871 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 15373767 | ||
| Pubmed | Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. | 2.07e-05 | 3 | 92 | 2 | 8833897 | |
| Pubmed | Expression and chain assembly of human laminin-332 in an insect cell-free translation system. | 2.07e-05 | 3 | 92 | 2 | 18603785 | |
| Pubmed | Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo. | 2.07e-05 | 3 | 92 | 2 | 23292142 | |
| Pubmed | Laminin-5 suppresses chondrogenic differentiation of murine teratocarcinoma cell line ATDC5. | 2.07e-05 | 3 | 92 | 2 | 16165127 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 33179081 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 15016838 | ||
| Pubmed | Fibroblasts contribute to the deposition of laminin 5 in the extracellular matrix. | 2.07e-05 | 3 | 92 | 2 | 15149852 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 24268577 | ||
| Pubmed | Expression of ERβ and its co-regulators p300 and NCoR in human transitional cell bladder cancer. | 2.07e-05 | 3 | 92 | 2 | 21525722 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 8113417 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 34390859 | ||
| Pubmed | Oligomerization of ETO is obligatory for corepressor interaction. | 2.07e-05 | 3 | 92 | 2 | 11113190 | |
| Pubmed | Dicer1 is required for differentiation of the mouse male germline. | 2.07e-05 | 3 | 92 | 2 | 18633141 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 27375110 | ||
| Pubmed | Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5. | 2.07e-05 | 3 | 92 | 2 | 16537560 | |
| Pubmed | Quantitative analysis of laminin 5 gene expression in human keratinocytes. | 2.07e-05 | 3 | 92 | 2 | 15854126 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 12011091 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 21518914 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 15802375 | ||
| Pubmed | Uncoordinated production of Laminin-5 chains in airways epithelium of allergic asthmatics. | 2.07e-05 | 3 | 92 | 2 | 16179086 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 36238311 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 17137774 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 10406466 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 36316474 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 18052923 | ||
| Pubmed | MicroRNA biogenesis is required for mouse primordial germ cell development and spermatogenesis. | 2.07e-05 | 3 | 92 | 2 | 18320056 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 11997503 | ||
| Pubmed | Differential expression of laminin-5 subunits during incisor and molar development in the mouse. | 2.07e-05 | 3 | 92 | 2 | 10853832 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 18852122 | ||
| Pubmed | 2.30e-05 | 21 | 92 | 3 | 19596656 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.71e-05 | 220 | 92 | 6 | 35785414 | |
| Pubmed | 2.85e-05 | 222 | 92 | 6 | 35941108 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 10651091 | ||
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 9819405 | ||
| Pubmed | The p46 subunit of eukaryotic initiation factor (eIF)-4F exchanges with eIF-4A. | 4.14e-05 | 4 | 92 | 2 | 8449919 | |
| Pubmed | Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers. | 4.14e-05 | 4 | 92 | 2 | 18362166 | |
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 18632669 | ||
| Pubmed | Dichotomous engagement of HDAC3 activity governs inflammatory responses. | 4.14e-05 | 4 | 92 | 2 | 32760002 | |
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 19147680 | ||
| Pubmed | Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. | 4.14e-05 | 4 | 92 | 2 | 10806203 | |
| Interaction | HNF1B interactions | 2.35e-06 | 190 | 91 | 8 | int:HNF1B | |
| Interaction | TLE3 interactions | 7.61e-06 | 376 | 91 | 10 | int:TLE3 | |
| Interaction | ERG interactions | 7.66e-06 | 223 | 91 | 8 | int:ERG | |
| Interaction | TBR1 interactions | 1.23e-05 | 113 | 91 | 6 | int:TBR1 | |
| Interaction | EGR2 interactions | 1.25e-05 | 171 | 91 | 7 | int:EGR2 | |
| Interaction | GCM1 interactions | 1.40e-05 | 68 | 91 | 5 | int:GCM1 | |
| Interaction | PAX7 interactions | 2.09e-05 | 124 | 91 | 6 | int:PAX7 | |
| Interaction | TRIM37 interactions | NCOR1 NCOR2 ATP1B4 SMG7 MYO1C EIF4A2 MAEA NFRKB ANKRD11 ZNF69 ZNF217 MVP | 2.60e-05 | 630 | 91 | 12 | int:TRIM37 |
| Interaction | FEV interactions | 3.76e-05 | 203 | 91 | 7 | int:FEV | |
| Interaction | TTC23 interactions | 4.38e-05 | 208 | 91 | 7 | int:TTC23 | |
| Interaction | FXR1 interactions | NCOR1 NCOR2 SMG7 PDE9A MYO1C C9orf78 OTUD4 DNAJA1 MVP CBS CNOT1 EP300 | 5.37e-05 | 679 | 91 | 12 | int:FXR1 |
| Interaction | CLK1 interactions | 6.07e-05 | 219 | 91 | 7 | int:CLK1 | |
| Interaction | ZBTB5 interactions | 7.06e-05 | 49 | 91 | 4 | int:ZBTB5 | |
| Interaction | KLF3 interactions | 7.82e-05 | 228 | 91 | 7 | int:KLF3 | |
| Interaction | TOP3B interactions | NCOR1 NCOR2 RBM15 FAT1 SMG7 CELSR3 MYO1C EIF4A1 EIF4A2 MAEA ANKRD11 OTUD4 LAMB3 DNAJA1 CNOT1 EP300 MADD ITPR3 | 8.68e-05 | 1470 | 91 | 18 | int:TOP3B |
| Interaction | SMG7 interactions | 9.82e-05 | 319 | 91 | 8 | int:SMG7 | |
| Interaction | CDC16 interactions | 1.26e-04 | 246 | 91 | 7 | int:CDC16 | |
| Interaction | TEAD1 interactions | 1.47e-04 | 176 | 91 | 6 | int:TEAD1 | |
| Interaction | PAX8 interactions | 1.48e-04 | 111 | 91 | 5 | int:PAX8 | |
| Interaction | CRX interactions | 1.53e-04 | 254 | 91 | 7 | int:CRX | |
| Interaction | LATS1 interactions | 1.67e-04 | 440 | 91 | 9 | int:LATS1 | |
| Interaction | NR6A1 interactions | 1.68e-04 | 24 | 91 | 3 | int:NR6A1 | |
| Interaction | TULP3 interactions | 1.72e-04 | 346 | 91 | 8 | int:TULP3 | |
| Interaction | ALG13 interactions | 1.82e-04 | 183 | 91 | 6 | int:ALG13 | |
| Interaction | GPHA2 interactions | 1.91e-04 | 25 | 91 | 3 | int:GPHA2 | |
| Interaction | MECOM interactions | 2.16e-04 | 358 | 91 | 8 | int:MECOM | |
| Interaction | LLCFC1 interactions | 2.21e-04 | 121 | 91 | 5 | int:LLCFC1 | |
| Interaction | SLAMF1 interactions | 2.57e-04 | 125 | 91 | 5 | int:SLAMF1 | |
| Cytoband | 10q24.2 | 8.94e-04 | 22 | 92 | 2 | 10q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | 9.97e-04 | 377 | 92 | 5 | chr21q22 | |
| Cytoband | 17q23.2 | 2.01e-03 | 33 | 92 | 2 | 17q23.2 | |
| Cytoband | Xq21.1 | 2.01e-03 | 33 | 92 | 2 | Xq21.1 | |
| Cytoband | 21q22.2 | 2.01e-03 | 33 | 92 | 2 | 21q22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q24 | 2.63e-03 | 136 | 92 | 3 | chr16q24 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CNTN4 CACNB3 SEMA6D CELSR3 PRSS53 TENM1 LAMA3 CYP4X1 OTUD4 NEB STEAP2 DICER1 AGTPBP1 MAP3K2 DOP1B BRWD1 | 1.20e-06 | 1106 | 91 | 16 | M39071 |
| Coexpression | DELACROIX_RAR_BOUND_ES | 3.49e-05 | 465 | 91 | 9 | M2466 | |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 4.09e-05 | 181 | 91 | 6 | M6849 | |
| Coexpression | GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP | 5.36e-05 | 190 | 91 | 6 | M3289 | |
| Coexpression | DELACROIX_RAR_BOUND_ES | 5.48e-05 | 493 | 91 | 9 | MM1079 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 7.12e-05 | 200 | 91 | 6 | M5282 | |
| Coexpression | GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN | 7.12e-05 | 200 | 91 | 6 | M6745 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-06 | 194 | 92 | 6 | a516839871c4e9683093a1c07b72c682f9ecbb3d | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.61e-06 | 199 | 92 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.71e-06 | 200 | 92 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-05 | 168 | 92 | 5 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-05 | 174 | 92 | 5 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-05 | 174 | 92 | 5 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 184 | 92 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 186 | 92 | 5 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 187 | 92 | 5 | 91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 187 | 92 | 5 | 382db691eb0b3e089e816bed3d6699cc2d4e1bda | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 188 | 92 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.77e-05 | 191 | 92 | 5 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 192 | 92 | 5 | 3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 4.89e-05 | 192 | 92 | 5 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 192 | 92 | 5 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 194 | 92 | 5 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-05 | 195 | 92 | 5 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 195 | 92 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 195 | 92 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.52e-05 | 197 | 92 | 5 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-05 | 199 | 92 | 5 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | distal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.79e-05 | 199 | 92 | 5 | 547a7c30abc730af2670aee00c7a6af60426c9ac | |
| ToppCell | distal-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.79e-05 | 199 | 92 | 5 | 97b475f9110ef7bb29d9cf2109b7e43177830f05 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.79e-05 | 199 | 92 | 5 | 6e8a44e46b46e87b81dbfc56fcbbcde166fd00fe | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.93e-05 | 200 | 92 | 5 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | medial-mesenchymal-Adventitial_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.93e-05 | 200 | 92 | 5 | 87a5a0c252c08ba10316c21f6a9d5244c4d98c74 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.93e-05 | 200 | 92 | 5 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | medial-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.93e-05 | 200 | 92 | 5 | 6ccf44f10d2cee5f48b8f05bd9a1b94057184d56 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.93e-05 | 200 | 92 | 5 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | medial-mesenchymal-Adventitial_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.93e-05 | 200 | 92 | 5 | 5ee1318a74ca28a81bd81c20c611de84c17636b0 | |
| ToppCell | Control-NK_activated|Control / Disease condition and Cell class | 1.09e-04 | 119 | 92 | 4 | 0d0bab03d56e269c6e637b0bbeffe9d1491dfc33 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.67e-04 | 133 | 92 | 4 | d5326a6ccada5ae6d3e8f7d4a858c90050e23c5b | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.14e-04 | 142 | 92 | 4 | 58bfff3284ae21150e4619511bd58622c16c5dde | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.14e-04 | 142 | 92 | 4 | 5fd737c1fee9d97aee8955f1bf378ead3fce138d | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.14e-04 | 142 | 92 | 4 | 16f9945e835c3506b12d904778560d065a50f059 | |
| ToppCell | IIH-CD4-CD8_1|IIH / Condition, Cell_class and T cell subcluster | 2.32e-04 | 145 | 92 | 4 | 296b6b0eea3233d76742ea35252b2f54d4c27ab6 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Rgs12_(Fast-spiking_interneuron,_Pvalb+/Rgs12+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.48e-04 | 59 | 92 | 3 | d49a63218a045f3d032d135aee234a3269222abd | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Rgs12_(Fast-spiking_interneuron,_Pvalb+/Rgs12+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.48e-04 | 59 | 92 | 3 | 2d77ae08fa9836bbae158a0e466806a5f9236b5e | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.78e-04 | 152 | 92 | 4 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tnc|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.92e-04 | 154 | 92 | 4 | 0066b2b8cfc74603e97f271ef5efc7ec512110dc | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 158 | 92 | 4 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 158 | 92 | 4 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 158 | 92 | 4 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.45e-04 | 161 | 92 | 4 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.54e-04 | 162 | 92 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.88e-04 | 166 | 92 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.97e-04 | 167 | 92 | 4 | 1e2fc1637769405a61f4c7e44945712a1888a299 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 4.06e-04 | 168 | 92 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.15e-04 | 169 | 92 | 4 | 29db25e7c5f31d98a08a35d7ec5ade203242bc50 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related-Oligodendrocyte/OPC|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.15e-04 | 169 | 92 | 4 | b1611e61f635f8f9b87250e026ad30999cbee041 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.34e-04 | 171 | 92 | 4 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.34e-04 | 171 | 92 | 4 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 4.53e-04 | 173 | 92 | 4 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 174 | 92 | 4 | ff13a5c55d18b951315908f33cb47c7f9cb901bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.73e-04 | 175 | 92 | 4 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.73e-04 | 175 | 92 | 4 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 4.84e-04 | 176 | 92 | 4 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.94e-04 | 177 | 92 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.05e-04 | 178 | 92 | 4 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.05e-04 | 178 | 92 | 4 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | ASK454-Epithelial-Ciliated|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.15e-04 | 179 | 92 | 4 | f21919ef9d3d984e2925ef3d24f89e20fe265dcd | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 5.15e-04 | 179 | 92 | 4 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-04 | 179 | 92 | 4 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 180 | 92 | 4 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.26e-04 | 180 | 92 | 4 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 180 | 92 | 4 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 180 | 92 | 4 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 5.48e-04 | 182 | 92 | 4 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-04 | 182 | 92 | 4 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | (00)_Basal-(0)_uninjured|(00)_Basal / shred by cell type and Timepoint | 5.48e-04 | 182 | 92 | 4 | c02c9cab4389d80f318f4bb8d703c1e719672624 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.60e-04 | 183 | 92 | 4 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | mild-B_cell|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.60e-04 | 183 | 92 | 4 | 175aaf8fbbff52eab87d78a49d5ab02cd489c438 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-04 | 184 | 92 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-04 | 184 | 92 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-04 | 184 | 92 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 5.71e-04 | 184 | 92 | 4 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.83e-04 | 185 | 92 | 4 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.83e-04 | 185 | 92 | 4 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-4|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.83e-04 | 185 | 92 | 4 | e1f3f0e974eb3fe1c05018beb9e124c7fb0cbe50 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 186 | 92 | 4 | e52cf44989c57c433bf82e9fa13b4643e88f3577 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.95e-04 | 186 | 92 | 4 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 186 | 92 | 4 | 4c0b59d845b79323e7a3287e7c4d249f5f322556 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Slc17a7-Slc17a6.Calb1-Rorb-Il1rapl2_(Layer_5b)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.07e-04 | 80 | 92 | 3 | 402aba070f0728ebda9db7a8fa85441533755ff4 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-04 | 187 | 92 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 6.07e-04 | 187 | 92 | 4 | a3592f056e1c2f82ba325fea2ecc4dd6c6347c81 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.07e-04 | 187 | 92 | 4 | d9d10ed7c905778a29a0dc3ced3eef02a6b1de5c | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 6.07e-04 | 187 | 92 | 4 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 6.07e-04 | 187 | 92 | 4 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.19e-04 | 188 | 92 | 4 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.19e-04 | 188 | 92 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.19e-04 | 188 | 92 | 4 | c74771584b3ba9561a99a54bf55a9203ddf8eff8 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.19e-04 | 188 | 92 | 4 | 9155b9a92496e75646778c025b02947e9e9ec73a | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.19e-04 | 188 | 92 | 4 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | droplet-Lung-21m-Epithelial-alveolar_epithelial-type_II_pneumocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.19e-04 | 188 | 92 | 4 | 068b761a7b6778bc6d6c776b5f09094aac87477e | |
| ToppCell | droplet-Lung-21m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.19e-04 | 188 | 92 | 4 | c95134245dab9057eb1f9b54acb371470f9c8b86 | |
| ToppCell | droplet-Lung-21m-Epithelial-alveolar_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.19e-04 | 188 | 92 | 4 | 3ee321a74f04eb0982c7b4977426946b0ae6e5a9 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.19e-04 | 188 | 92 | 4 | 5a89587ee6f2b4dc14244bd88bb31efb81c50dbe | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.19e-04 | 188 | 92 | 4 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-04 | 189 | 92 | 4 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.32e-04 | 189 | 92 | 4 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| Drug | halofenate | 2.55e-07 | 4 | 92 | 3 | CID000033584 | |
| Drug | Nifurtimox [23256-30-6]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.42e-06 | 198 | 92 | 8 | 7328_DN | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.30e-05 | 192 | 92 | 7 | 6254_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.54e-05 | 197 | 92 | 7 | 1497_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; PC3; HG-U133A | 1.69e-05 | 200 | 92 | 7 | 1915_DN | |
| Disease | Refractory anemia with ringed sideroblasts | 9.00e-06 | 2 | 89 | 2 | C1264195 | |
| Disease | Junctional epidermolysis bullosa | 2.69e-05 | 3 | 89 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 2.69e-05 | 3 | 89 | 2 | cv:C0079683 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 2.69e-05 | 3 | 89 | 2 | 226700 | |
| Disease | hair color | 4.45e-05 | 311 | 89 | 7 | EFO_0003924 | |
| Disease | Epidermolysis Bullosa Progressiva | 5.38e-05 | 4 | 89 | 2 | C0079297 | |
| Disease | Herlitz Disease | 5.38e-05 | 4 | 89 | 2 | C0079683 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 8.23e-05 | 28 | 89 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | MYELODYSPLASTIC SYNDROME | 8.94e-05 | 5 | 89 | 2 | 614286 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 8.94e-05 | 5 | 89 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 8.94e-05 | 5 | 89 | 2 | C2608084 | |
| Disease | Myelodysplastic syndrome | 8.94e-05 | 5 | 89 | 2 | cv:C3463824 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 8.94e-05 | 5 | 89 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Junctional Epidermolysis Bullosa | 1.34e-04 | 6 | 89 | 2 | C0079301 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 1.87e-04 | 7 | 89 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 1.87e-04 | 7 | 89 | 2 | C0399367 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.60e-04 | 41 | 89 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.60e-04 | 41 | 89 | 3 | C0858252 | |
| Disease | pulse pressure measurement | TET2 KCNE2 ARID1B ZFAT MYO1C MAEA TRIM8 ANKRD11 TRIM65 CHD2 STEAP2 CNOT1 MADD | 2.70e-04 | 1392 | 89 | 13 | EFO_0005763 |
| Disease | R-6-hydroxywarfarin measurement | 4.01e-04 | 114 | 89 | 4 | EFO_0803327 | |
| Disease | Oligospermia | 5.82e-04 | 12 | 89 | 2 | C0028960 | |
| Disease | facial pigmentation measurement | 6.90e-04 | 57 | 89 | 3 | EFO_0006942 | |
| Disease | Metabolic Bone Disorder | 8.00e-04 | 14 | 89 | 2 | C0005944 | |
| Disease | Down syndrome (implicated_via_orthology) | 9.21e-04 | 15 | 89 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Osteopenia | 9.21e-04 | 15 | 89 | 2 | C0029453 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 9.21e-04 | 15 | 89 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.18e-03 | 152 | 89 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.28e-03 | 702 | 89 | 8 | C0009402 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 1.82e-03 | 21 | 89 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | Epilepsy, Cryptogenic | 1.98e-03 | 82 | 89 | 3 | C0086237 | |
| Disease | response to selective serotonin reuptake inhibitor | 1.98e-03 | 82 | 89 | 3 | EFO_0005658 | |
| Disease | Awakening Epilepsy | 1.98e-03 | 82 | 89 | 3 | C0751111 | |
| Disease | Aura | 1.98e-03 | 82 | 89 | 3 | C0236018 | |
| Disease | thyroxine measurement | 2.05e-03 | 83 | 89 | 3 | EFO_0005130 | |
| Disease | carotid plaque build | 2.12e-03 | 84 | 89 | 3 | EFO_0006501 | |
| Disease | Autism Spectrum Disorders | 2.19e-03 | 85 | 89 | 3 | C1510586 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 2.38e-03 | 24 | 89 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | migraine disorder, diastolic blood pressure | 2.58e-03 | 25 | 89 | 2 | EFO_0006336, MONDO_0005277 | |
| Disease | breast cancer (implicated_via_orthology) | 2.58e-03 | 25 | 89 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | forced expiratory volume | 2.65e-03 | 789 | 89 | 8 | EFO_0004314 | |
| Disease | Neurodevelopmental Disorders | 2.83e-03 | 93 | 89 | 3 | C1535926 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.92e-03 | 195 | 89 | 4 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GDNYRVNNKHDDRYT | 71 | Q9NWW9 | |
| HYRTDSRGVNLNRQY | 301 | Q8NDL9 | |
| ESANNRAEYYHLLAE | 621 | Q09472 | |
| HSDRANPYFEYLQIR | 2431 | Q6UB99 | |
| DAYQDLYQPHRQHTS | 431 | P54284 | |
| HYRVEPRDSNEFYGN | 811 | Q8WXG9 | |
| EYPSYQDNRRFVSQE | 161 | Q8IWV2 | |
| RYIEHNARTFNEPDS | 1211 | Q6RI45 | |
| GQNRRNEDLYHQSYE | 856 | Q8NFM4 | |
| RQQFPYGASYDRRHE | 1396 | Q8NFD5 | |
| YRNFDQPHRFYVADV | 936 | Q9UPY3 | |
| FDPNQERRRHYNGEA | 366 | P31689 | |
| PESNYYEHICHFRNR | 896 | Q9UPW5 | |
| SYRYRLDDPDEANQN | 16 | Q9UN42 | |
| NSRYLHDNIVDYAQR | 81 | Q8IUZ5 | |
| PDPNNYYHRRNEMTT | 296 | Q8N436 | |
| SRESIQEPRSDYYNH | 616 | Q7Z5L2 | |
| FADTEHRYQQQYLQP | 526 | Q96T37 | |
| QPSRSRDEGYQYHRN | 1076 | Q01804 | |
| NYRALYPFEARNHDE | 761 | Q9NZM3 | |
| RAGNAHDENVLSYYR | 716 | Q14573 | |
| PESYYVQDNGRNVHL | 466 | Q8IZ07 | |
| EYRGRHCEDAAPNQY | 4156 | Q14517 | |
| LYNQPSDTRQYHENI | 256 | Q9Y618 | |
| SSYIQNAYDLPRNSH | 1006 | A6BM72 | |
| SDNVLYQNRNYHLTP | 361 | Q7Z353 | |
| QLQPIHYRVYDSNSQ | 586 | Q8WXG6 | |
| RYDNYRLHQLGNNSV | 271 | Q7L5Y9 | |
| HASNCYYDPDVERQQ | 361 | Q16787 | |
| FQEQERYRYSQPHKA | 521 | Q6P4R8 | |
| HSQQRQYRSAYYPED | 351 | P51654 | |
| YLRNHSAYNAPSFRA | 1936 | Q9Y3R5 | |
| NYDLPTNRENYIHRI | 346 | P60842 | |
| HPGYNNTYQINARTE | 356 | O76083 | |
| RQNIDAYHNPDARTY | 696 | Q1MSJ5 | |
| KEDIPNRFYYQHNDR | 296 | Q9Y6X5 | |
| NRFYYQHNDRIQPII | 301 | Q9Y6X5 | |
| RAQSYPDNHQEFSDY | 236 | Q9Y2U5 | |
| YEFLQEHFNPQRRYN | 246 | Q96A46 | |
| RREHSNDPYHQYIVE | 76 | Q9Y6J6 | |
| RVPHNAAVQVYDYRE | 461 | Q14764 | |
| YAHNNYQAQSAVPLR | 436 | P05186 | |
| AAELDQQERQHYRDY | 201 | A8MW95 | |
| YQSYEHRSPSPNIRN | 71 | A2AJT9 | |
| RDHYNCTQFPYREDQ | 626 | P0C671 | |
| RRSDEFRPQNYHQQD | 1726 | O14647 | |
| FSQENSDQRHPYAYL | 431 | Q8N118 | |
| DQYRNASNPLAHYDT | 221 | P35520 | |
| PNSARVRYYQSLQAH | 201 | P51993 | |
| HTDYRPLIRDSNNYV | 561 | Q9NSI6 | |
| INYDLPTNRENYIHR | 346 | Q14240 | |
| IRNRTPFASAENHNY | 516 | Q8NA82 | |
| SRQPHNYYSHRVENV | 71 | Q13751 | |
| AAANAHQDRYYQTDL | 216 | O94868 | |
| RNDHSPVFEQAQYRE | 426 | Q9NYQ7 | |
| LYDAYVNRNSSHNSR | 396 | Q8N7B9 | |
| DTQYRRSCAVEYPHQ | 536 | Q96BN6 | |
| HQATPRQRYQAARIY | 721 | Q9BQS7 | |
| NTRHQQEFAVPDYRS | 31 | O75376 | |
| AESYYRHAAQLVPSN | 171 | Q92540 | |
| GDRYRTEQYQSSPHE | 546 | P81133 | |
| AVNYHYQQIDRQQPS | 396 | Q86YJ6 | |
| PRQSYNSRETLHEYN | 36 | Q9UKZ4 | |
| HSQRRYIFEYDQPDC | 1896 | Q9UKZ4 | |
| IHPYARNQQSDFYKI | 236 | Q8NFT2 | |
| FYPYSRNHNIANTRR | 1551 | P14410 | |
| DNFYPERFTYHNVRL | 366 | Q8TE77 | |
| QPYLNKLNYRRTDHE | 851 | O75339 | |
| FDKILYNRQQHYDPR | 571 | Q03692 | |
| DEANSYFQRIYNHPP | 846 | A5YKK6 | |
| YRRHRNPSTADAYNS | 121 | Q96N06 | |
| VAALQLPRAYNHYSQ | 111 | Q2L4Q9 | |
| QPYYEEQARLSRQHL | 471 | Q9UN79 | |
| RHYNRKHPNEEYANV | 1011 | Q9P243 | |
| AHGRPYLQDYFTNAN | 81 | Q6UVY6 | |
| SQDALIAHYPRIYND | 1276 | O75533 | |
| YDEAYRQNPHDASLA | 751 | Q8NDW8 | |
| HLDRYFYHVNNDQPI | 776 | Q63HK5 | |
| NIEYEYQNPRRNFRS | 71 | Q9UC07 | |
| HQRTHTLDNPYEYEN | 431 | P52738 | |
| NYENFIGNAHYRPND | 1031 | O75362 | |
| YVQHNRFYHEELNAP | 221 | Q9NZ63 | |
| NIEYEYQNPRRNFRS | 51 | Q0D2J5 | |
| DDEPLNTVDYHYSRQ | 26 | Q8NFY4 | |
| DVYRRDQIDSQHYPI | 176 | O95363 | |
| PQHNAYRLYHCEAEQ | 146 | Q9BZR9 | |
| DASQQPGHQDFYRVY | 526 | Q9BZR9 | |
| DPVSANRHFYLSRQD | 336 | Q6PJ69 | |
| APDAYNNQIEYEHRA | 1341 | Q6N021 | |
| HQNFRRFRYQEAASP | 46 | O95125 | |
| ENFRVQYTETEPYHN | 386 | Q86VM9 | |
| NIEYEYQNPRRNFRS | 66 | Q8NDP4 | |
| YNNDRILVRHIDSYN | 506 | Q96NJ5 | |
| SVNPYRDLQIYSRQH | 86 | O00159 | |
| IHARQAYDLQSDNLY | 2641 | P20929 |